A: BPC-157 is studied in preclinical research for its potential role in tissue healing, gastrointestinal protection, and angiogenic processes
In the risks and discomfort section, identify any potential side effects or complications associated with the injection
After spending time on the FDA's Category 2 list flagged for "significant safety concerns" BPC-157 is now being removed from that restrictive classification and scheduled for a Pharmacy Compounding Advisory Committee (PCAC) review on July 23, 2026
For researchers who want deeper guidance on any of these topics, SeekPeptides provides comprehensive protocols, dosing calculators, and expert-reviewed guides covering every aspect of peptide research from reconstitution through complete multi-week protocols
doi: 10.3389/fphar.2022.1026182
World Anti-Doping Agency World Anti-Doping Code International Standard Prohibited List 2025